BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

519 related articles for article (PubMed ID: 28160779)

  • 1. miR-3156-3p is downregulated in HPV-positive cervical cancer and performs as a tumor-suppressive miRNA.
    Xia YF; Pei GH; Wang N; Che YC; Yu FS; Yin FF; Liu HX; Luo B; Wang YK
    Virol J; 2017 Feb; 14(1):20. PubMed ID: 28160779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serine/threonine kinases 31(STK31) may be a novel cellular target gene for the HPV16 oncogene E7 with potential as a DNA hypomethylation biomarker in cervical cancer.
    Yin FF; Wang N; Bi XN; Yu X; Xu XH; Wang YL; Zhao CQ; Luo B; Wang YK
    Virol J; 2016 Apr; 13():60. PubMed ID: 27044426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Papillomavirus 16 Oncoproteins Downregulate the Expression of miR-148a-3p, miR-190a-5p, and miR-199b-5p in Cervical Cancer.
    Han MS; Lee JM; Kim SN; Kim JH; Kim HS
    Biomed Res Int; 2018; 2018():1942867. PubMed ID: 30627542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The HPV16 E6, E7/miR-23b-3p/ICAT signaling axis promotes proliferation, migration, invasion and EMT of cervical cancer cells.
    Hu J; Liao D; Sun Z; Ren W; Zhao L; Fang Y; Hu K; Yu H; Liu S; Zhou L; He T; Zhang Y
    Carcinogenesis; 2023 May; 44(3):221-231. PubMed ID: 36847693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dependence of intracellular and exosomal microRNAs on viral E6/E7 oncogene expression in HPV-positive tumor cells.
    Honegger A; Schilling D; Bastian S; Sponagel J; Kuryshev V; Sültmann H; Scheffner M; Hoppe-Seyler K; Hoppe-Seyler F
    PLoS Pathog; 2015 Mar; 11(3):e1004712. PubMed ID: 25760330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-27b up-regulated by human papillomavirus 16 E7 promotes proliferation and suppresses apoptosis by targeting polo-like kinase2 in cervical cancer.
    Liu F; Zhang S; Zhao Z; Mao X; Huang J; Wu Z; Zheng L; Wang Q
    Oncotarget; 2016 Apr; 7(15):19666-79. PubMed ID: 26910911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-331-3p Suppresses Cervical Cancer Cell Proliferation and E6/E7 Expression by Targeting NRP2.
    Fujii T; Shimada K; Asano A; Tatsumi Y; Yamaguchi N; Yamazaki M; Konishi N
    Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27548144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of miR-409-3p in regulation of HPV16/18-E6 mRNA in human cervical high-grade squamous intraepithelial lesions.
    Sommerova L; Anton M; Bouchalova P; Jasickova H; Rak V; Jandakova E; Selingerova I; Bartosik M; Vojtesek B; Hrstka R
    Antiviral Res; 2019 Mar; 163():185-192. PubMed ID: 30711417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus type 16 E7 promotes cell viability and migration in cervical cancer by regulating the miR-23a/HOXC8 axis.
    Chen Y; Sun L; Li L
    J Obstet Gynaecol; 2024 Dec; 44(1):2311658. PubMed ID: 38348790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HPV16 E6 and E7 upregulate the histone lysine demethylase KDM2B through the c-MYC/miR-146a-5p axys.
    Peta E; Sinigaglia A; Masi G; Di Camillo B; Grassi A; Trevisan M; Messa L; Loregian A; Manfrin E; Brunelli M; Martignoni G; Palù G; Barzon L
    Oncogene; 2018 Mar; 37(12):1654-1668. PubMed ID: 29335520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ARFHPV E7 oncogene, lncRNA HOTAIR, miR-331-3p and its target, NRP2, form a negative feedback loop to regulate the apoptosis in the tumorigenesis in HPV positive cervical cancer.
    Zhang M; Song Y; Zhai F
    J Cell Biochem; 2018 Jun; 119(6):4397-4407. PubMed ID: 29130509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-10b Downregulated by DNA Methylation Acts as a Tumor Suppressor in HPV-Positive Cervical Cancer via Targeting Tiam1.
    Yu M; Xu Y; Pan L; Feng Y; Luo K; Mu Q; Luo G
    Cell Physiol Biochem; 2018; 51(4):1763-1777. PubMed ID: 30504727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HPV E7 affects the function of cervical cancer cells via the TAL1/lnc‑EBIC/KLHDC7B axis.
    Wang J; Xiang F; Liu X; Ma X; Cai X; Yang Y; Shen X; Yuan C; Xiang Y; Xiao H
    Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus 16 E6/E7 contributes to immune escape and progression of cervical cancer by regulating miR-142-5p/PD-L1 axis.
    Ling J; Sun Q; Tian Q; Shi H; Yang H; Ren J
    Arch Biochem Biophys; 2022 Nov; 731():109449. PubMed ID: 36288761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of miR-200a-3p with YAP regulates cell proliferation and metastasis differentially in HPV-positive and HPV-negative cervical cancer cells.
    Chen H; Gu L; Zhang M; Chen H; Liao H; Cao X; Yu L; Zhang J
    BMC Cancer; 2022 Oct; 22(1):1039. PubMed ID: 36195847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3.
    Yin F; Wang N; Wang S; Yu F; Sun X; Yu X; Luo B; Zhao C; Wang Y
    Oncol Rep; 2017 Apr; 37(4):2324-2334. PubMed ID: 28260046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miRNA Expression Profiles of HPV-Infected Patients with Cervical Cancer in the Uyghur Population in China.
    Gao D; Zhang Y; Zhu M; Liu S; Wang X
    PLoS One; 2016; 11(10):e0164701. PubMed ID: 27764149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-182 plays an onco-miRNA role in cervical cancer.
    Tang T; Wong HK; Gu W; Yu MY; To KF; Wang CC; Wong YF; Cheung TH; Chung TK; Choy KW
    Gynecol Oncol; 2013 Apr; 129(1):199-208. PubMed ID: 23313739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of miR-93-5p inhibits high-risk HPV-positive cervical cancer progression via targeting of BTG3.
    Li J; Chu ZP; Han H; Zhang Y; Tian F; Zhang JQ; Huang XH
    Hum Cell; 2019 Apr; 32(2):160-171. PubMed ID: 30689165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HPV16 E6 promoting cervical cancer progression through down-regulation of miR-320a to increase TOP2A expression.
    Zhang J; Yu X; Guo Y; Wang D
    Cancer Med; 2024 Feb; 13(3):e6875. PubMed ID: 38205938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.